Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2008
07/24/2008US20080176875 Substituted quinazolines
07/24/2008US20080176870 Heterobicyclic metalloprotease inhibitors
07/24/2008US20080176868 Preparation and use of compounds as protease inhibitors
07/24/2008US20080176847 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/24/2008US20080176846 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent
07/24/2008US20080176830 Compounds, Compositions, and Methods
07/24/2008US20080176827 e.g. ethyl 6-(3-{2-[(benzylsulfonyl)amino]-2-oxoethyl}pyrrolidin-1-yl)-5-cyano-2-methylnicotinate; P2Y12 (G-protein coupled receptor) antagonist and anti-trombotic agent; high potency and selectivity; cardiovascular disorders, platelet aggregation disorder, acute thrombotic occlusion
07/24/2008US20080176822 Novel composition for treating metabolic syndrome
07/24/2008US20080176819 with a water-insoluble cellulose derivative such as ethyl cellulose; cardiovascular disease or Type II diabetes
07/24/2008US20080176815 Compounds that interact with kinases
07/24/2008US20080176810 Use of 3, 4', 5-Trihydroxy-Stilbene-3-Beta-D-glucoside in Prepartion of Medicines For Treating and/or Preventing Ischemic Heart Disease
07/24/2008US20080176809 Use of D-ribose to treat cardiac arrhythmias
07/24/2008US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates
07/24/2008US20080176796 screening for selective antagonists or agonists of tumor necrosis factor receptors, used as antiinflammatory or antiischemic agents; treatment of cardiovascular and kidney diseases
07/24/2008US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones
07/24/2008US20080175893 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure
07/24/2008US20080175891 transdermal patches for drug delivery AICA riboside, a prodrugs, or antiischemic agent; provides heat, modulation of blood flow; pre- or after-treatment of surgery; including anticoagulants, allopurinol; drug delivery device for sustained release
07/24/2008US20080175884 Polymer coatings as carriers for the drug delivery of a methosyaminocarbonyloxy derivative of rapamycin and another drug(s) such as an antiproliferative agent, anticoagulant, etc.; reduces restenosis in vasculature procedures to a level of 0-25%; coronary/periferal stents; grafts ; balloons
07/24/2008US20080175880 Pyridoxal-5-Phosphate And Stent For The Treatment And Prevention Of Atherosclerosis And Restenosis
07/24/2008US20080175872 Controlled Release Dosage Form Containing Lercanidipine and a Performance-enhancing Acid
07/24/2008US20080175840 Methods for treating angiogenesis related disorders
07/24/2008US20080175833 Using alpha -glucosidase administration to treat defects in glycogen synthesis or breakdown within muscles, liver and other cell types
07/24/2008US20080175828 Proliferated cell lines and uses thereof
07/24/2008DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives
07/24/2008DE102007002715A1 Triazolderivat Triazole derivative
07/24/2008CA2675836A1 Composition for preventing or treating thrombus- or embolus-associated disease
07/24/2008CA2675733A1 Method for glycosylation of flavonoid compounds
07/24/2008CA2675520A1 New combination for use in the treatment of inflammatory disorders
07/24/2008CA2675176A1 Levosimendan for use in treating chronic valvular disease
07/24/2008CA2675157A1 Fibrin gel for controlled release of tgf-beta and uses thereof
07/24/2008CA2674949A1 Targeting ncca-atp channel for organ protection following ischemic episode
07/24/2008CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity
07/23/2008EP1947192A2 Preventive/remedy for arteriosclerotic disease and method of evaluating therapeutic procedure
07/23/2008EP1947109A2 Biologically active peptides
07/23/2008EP1947101A1 Hydrazide compound and thrombopoietin receptor activator
07/23/2008EP1946774A1 Cerebral infarction-preventive agent
07/23/2008EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient
07/23/2008EP1946762A1 Scavenger of harmful active oxygen and/or free radical in living body
07/23/2008EP1946755A1 Jelly composition
07/23/2008EP1946749A1 Anti-angionene compositions and methods of use
07/23/2008EP1945633A1 Compounds and compositions as ppar modulators
07/23/2008EP1945242A2 Inhibition of extracellular signal-regulated kinase 1/2 as a treatment for cardiac hypertrophy and heart failure
07/23/2008EP1945238A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts
07/23/2008EP1732933B1 Compounds for treating dyslipidemia
07/23/2008EP1732534B1 Use of methylene amide derivatives in cardiovascular disorders
07/23/2008EP1685108B1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
07/23/2008EP1671949B1 Substituted Pyridinylamines
07/23/2008EP1601349B1 Use of the enantiomer (1s, 2r) of milnacipran for the preparation of a medicament
07/23/2008EP1562572B1 Pharmaceutical Solid Dispersions of Modafinil Compounds
07/23/2008EP1523988B1 Composition comprising radix codonopsis pilosulae and radix astragali for the treatment of acute lung injury
07/23/2008EP1499289B1 Volume efficient controlled release dosage form
07/23/2008EP1471901B1 Spermidine derivative for the treatment of chronic neurodegenerative diseases
07/23/2008EP1441757B1 Non-neurotoxic plasminogen activating factors for treating stroke
07/23/2008EP1420774B1 Preparation and diabetic use of gibberellins
07/23/2008EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists
07/23/2008EP1325745B1 Preventives and remedies for complications of diabetes
07/23/2008EP1315715B1 Quinazoline derivatives as kinase inhibitors
07/23/2008EP1294382B1 7-hydroxyepiandrosterone having neuroprotective activity
07/23/2008EP1272167B1 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
07/23/2008EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES
07/23/2008EP1141241B1 Adult human astrocytes, preparation of the same, and uses thereof
07/23/2008EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
07/23/2008EP1073638B1 Heterocyclically substituted amides, their production and their use
07/23/2008EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors
07/23/2008EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis
07/23/2008EP0978284B1 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists
07/23/2008EP0711158B2 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
07/23/2008CN101228149A Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors
07/23/2008CN101228132A Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors
07/23/2008CN101228126A Process for the preparation of crystalline perindopril
07/23/2008CN101227911A Use of spirostenols to treat mitochondrial disorders
07/23/2008CN101227908A Compositions for reducing the incidence of drug induced arrhythmia
07/23/2008CN101227902A New crystalline form of perindopril erbumine
07/23/2008CN101227836A Lycopene formulations for the treatment of atherosclerotic conditions
07/23/2008CN101227827A Packaged black coffee drink
07/23/2008CN101225424A Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof
07/23/2008CN101225398A Technology for preparing active t-PA by procaryotic cells
07/23/2008CN101225365A Composite bacteria leaven and preparation method thereof
07/23/2008CN101225106A Short peptide suppressing growth of cancer cell and uses thereof
07/23/2008CN101225105A Miscellaneous fish enzymolysis polypeptide and uses thereof
07/23/2008CN101225081A Isoflavone compound, preparation method and use thereof
07/23/2008CN101225040A Method for extracting crocetin from gardenia
07/23/2008CN101224285A Medicine for synchronously detecting, treating and preventing stroke and preparing method thereof
07/23/2008CN101224274A Medicine compounds of pericarp trichosanthis, longstamen onion bulb extract and preparing method thereof
07/23/2008CN101224262A Chinese traditional medicine compounds for treating asthenia of qi and blood type vasculitis and preparing method thereof
07/23/2008CN101224260A Health product compounds consisting of lecithin, grape seed extract and ginkgo leaf extract
07/23/2008CN101224255A Chinese traditional medicine compounds for treating hypertension
07/23/2008CN101224250A Preparing method for extracting medicinal evodia alkaloid by ultrasound
07/23/2008CN101224243A Chinese traditional medicine for treating cardiovascular and cerebrovascular disease
07/23/2008CN101224234A Medicine compounds and applications in treating or preventing blood vessel inflammation medicine
07/23/2008CN101224228A Panax notoginseng saponins freeze-dried powder injection and preparing method thereof
07/23/2008CN101224226A Novel clinical uses of big nilgiri nettle
07/23/2008CN101224223A Application of HCl in preparing medicine for treating gastritis, enteritis and vasculitis
07/23/2008CN101224198A Preparing method of breviscapinun dropping pills
07/23/2008CN101224187A Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel
07/23/2008CN101224078A Silk pillow capable of permanently sending out tea perfume and producing method thereof
07/23/2008CN100404682C Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application
07/23/2008CN100404529C 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound
07/23/2008CN100404514C 2-substituted phenyl-4,4,5,5-tetramethyl-1,3,-dioxy imidazolines, their preparation and pharmaceutical use
07/23/2008CN100404513C 2-substituted-4,4,5,5-tetramethyl-1-oxyimidazoline, and its synthesis and use